Replies to post #47236 on Starfleet Innotech Inc (SFIO)

[malvern]

True statement, maybe their is more succession taking place, that's the only way I think the lack of PR's can be excused, and frankly maybe the only way the company can emerge intact and trading, we really need a weekend PR.

[truescammer]

Just because a company has a patent doesnt mean its product is worth anything. I have an associate that has over 3000 liquer stores and he would not stock SFIO. Roth and Dunn are not going to be able to run this. That is why I sold out, took a profit and holding on until they post revenues and get out of debt. I have known many companies that get patents and dont go anywhere or bigger companies that actually "HAVE" money come in and reverse engineer and nitch the patent.

SFIO might be to late with all the big companies with all eyes on the 3 stocks on that trade on the market and sell e-cigs in the USA. Only time will tell but this company is way to dark.

[pegasus1]

Agree 100%. All of the officers had a duty to protect shareholders. Odds are there will now be a class action lawsuit as lawyers troll for this kind of snafu. I personally hope that doesn't happen as it probably won't benefit shareholders and only drive the price down if we survive this DTCC lock issue.

Frustrating. I don't get the TS defenders who say he was screwed. Would perhaps believe he may not have been aware of the rules and might have been manipulated by unscrupulous promoters or scammers, but that's no excuse. Know the rules or don't try to run a public company.

In a past life I worked for a publicly traded OTC/pink sheets company. The number of unscrupulous vultures and scammers that targeted the company daily was unbelievable. Quite an industry out there, scoping out the pinkies and BB's who are typically strapped for capital and desperate for funding.

Off my soapbox now. Got taken on another OTC/pink sheet company only a year ago. EGMI. Still waiting for something to happen. Class action lawsuit, bankruptcy and lots of unanswered questions.